Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

But only 1 in 4 have it under control ... lowering blood pressure. While effective, ACE inhibitors shouldn't be taken while you're pregnant or if you're trying to have a baby.

Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, and hypertension. Pharmac ...

RADNOR, Pa. - Mineralys Therapeutics , Inc. (NASDAQ:MLYS), a biopharmaceutical company specializing in the development of treatments for cardiovascular and kidney diseases, has announced the ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is administered to reduce morbidity and mortality. Limited access to ...

In a previous column, I discussed some common medications that can cause or worsen dry skin. In this column, we’ll look at three common medications that may contribute to hair loss or thinning by ...

The following is a summary of “Differences between private and public primary health care centers and differences between men and women in antihypertensive care and cardiovascular prevention in all ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Background/Aim Use of ACE inhibitors (ACEIs) has been associated with an increased ... neither in the main analysis (OR 1.06, 95% CI 1.04 to 1.08) nor in any of the sensitivity or stratified analyses.